摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3-(Pyrazin-2-yloxy)phenyl)methanamine

中文名称
——
中文别名
——
英文名称
(3-(Pyrazin-2-yloxy)phenyl)methanamine
英文别名
(3-pyrazin-2-yloxyphenyl)methanamine
(3-(Pyrazin-2-yloxy)phenyl)methanamine化学式
CAS
——
化学式
C11H11N3O
mdl
——
分子量
201.22
InChiKey
JAKUXBNMNUVHLE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    15
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    61
  • 氢给体数:
    1
  • 氢受体数:
    4

文献信息

  • SUBSTITUTED SULFONAMIDE COMPOUNDS
    申请人:OBERBOERSCH Stefan
    公开号:US20080153843A1
    公开(公告)日:2008-06-26
    Substituted sulfonamide derivatives, a process for their preparation, pharmaceutical compositions containing these compounds, and to the use of substituted sulfonamide derivatives in the treatment or inhibition of pain and/or various disorders or disease states.
    磺胺取代物,其制备方法,含有这些化合物的药物组合物,以及磺胺取代物在治疗或抑制疼痛和/或各种疾病或疾病状态中的用途。
  • [EN] AMINO-TETRAZOLES ANALOGUES AND METHODS OF USE<br/>[FR] ANALOGUES D'AMINO-TÉTRAZOLES ET MÉTHODES D'UTILISATION
    申请人:ABBOTT LAB
    公开号:WO2005111003A1
    公开(公告)日:2005-11-24
    A compound having Formula (I) or Formula (II) is disclosed as an P2X7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R1, R2, R3, R4, and R5, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X7 are also disclosed.
    公开了具有化学式(I)或化学式(II)的化合物作为P2X7拮抗剂,其中A、B、C、Y、Y、Z、m、v、R1、R2、R3、R4和R5如描述中所定义。还公开了用于治疗受P2X7调节的疾病或症状的方法和组合物。
  • [EN] DPP-IV INHIBITORS<br/>[FR] INHIBITEURS DE LA DPP-IV
    申请人:GRAFFINITY PHARMACEUTICALS AG
    公开号:WO2005095343A1
    公开(公告)日:2005-10-13
    The invention relates to compounds of formula (I), Z-C(R<1>R<2>)-C(R<3>NH2)-C(R<4>R<5>)-X-N(R<6>R<7>), wherein Z, R<1-7> and X have the meaning as cited in the description and the claims. Said compounds are useful as DPP-lV inhibitors. The invention also relates to the preparation of such compounds as well as the production and use thereof as medicament.
    该发明涉及式(I)的化合物,其中Z-C(R1R2)-C(R3NH2)-C(R4R5)-X-N(R6R7),其中Z,R1-7和X的含义如描述和权利要求中所述。所述化合物可用作DPP-IV抑制剂。该发明还涉及制备此类化合物以及其作为药物的生产和使用。
  • Amino-tetrazole analogues and methods of use
    申请人:Carroll A. William
    公开号:US20060052374A1
    公开(公告)日:2006-03-09
    A compound having Formula (I) or Formula (II) is disclosed as an P2X 7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R 1 , R 2 , R 3 , R 4 , and R 5 , are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X 7 are also disclosed.
    本文披露一种化合物,其化学式为(I)或(II),作为P2X7拮抗剂,其中A、B、C、Y、Y、Z、m、v、R1、R2、R3、R4和R5如描述中所定义。同时,本文还披露了治疗P2X7调节的疾病或病症的方法和组合物。
  • Amino-Tetrazoles Analogues and Methods of Use
    申请人:Carroll William A.
    公开号:US20080171733A1
    公开(公告)日:2008-07-17
    A compound having Formula (I) or Formula (II) is disclosed as an P2X 7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R 1 , R 2 , R 3 , R 4 , and R 5 , are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X 7 are also disclosed.
    本发明揭示了一种具有公式(I)或公式(II)的化合物,作为P2X7拮抗剂,其中A,B,C,Y,Y,Z,m,v,R1,R2,R3,R4和R5如描述中所定义。还揭示了用于治疗受P2X7调节的疾病或病况的方法和组合物。
查看更多